Mark Roest
- Hematology top 0.5%
- Platelet Disorders and Treatments 52
- Blood Coagulation and Thrombosis Mechanisms 25
- Hemophilia Treatment and Research 7
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 26
- Nephrology top 5%
-
- Antiplatelet Therapy and Cardiovascular Diseases 23
- Rheumatology top 2%
-
- Blood properties and coagulation 11
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 9
-
- Heparin-Induced Thrombocytopenia and Thrombosis 8
- Co-authors
- Philip G. de GrootRolf T. UrbanusBas de LaatDana HuskensYaqiu SangFrits R. RosendaalAle AlgraBob Siegerink
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
Mark Roest
114 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Hematology 1.2k
- Internal Medicine 359
- Nephrology 202
- Cardiology and Cardiovascular Medicine 648
- Rheumatology 404
Countries citing papers authored by Mark Roest
This map shows the geographic impact of Mark Roest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Roest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Roest more than expected).
Fields of papers citing papers by Mark Roest
This network shows the impact of papers produced by Mark Roest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Roest. The network helps show where Mark Roest may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Roest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 20 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 4 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 20 | |
| 13 | 2017 | 42 | |
| 14 | 2017 | 7 | |
| 15 | 2016 | 20 | |
| 16 | 2013 | 29 | |
| 17 | 2013 | 19 | |
| 18 | 2011 | 24 | |
| 19 | ENDOTHELIAL AND THROMBOCYTE ACTIVATION ARE NOT MEDIATORS IN EARLY ISCHEMIA-REPERFUSION INJURY IN HUMAN KIDNEY TRANSPLANTATION | 2010 | 3 |
| 20 | 2009 | 300 |
About Mark Roest
Mark Roest is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 118 papers that have together received 3.0k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (52 papers), Venous Thromboembolism Diagnosis and Management (26 papers), Blood Coagulation and Thrombosis Mechanisms (25 papers), Antiplatelet Therapy and Cardiovascular Diseases (23 papers), Blood properties and coagulation (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Hemophilia Treatment and Research (7 papers). The work is most often cited by research in Hematology (1.2k citations), Internal Medicine (359 citations) and Nephrology (202 citations). Mark Roest has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Philip G. de Groot, Rolf T. Urbanus, Bas de Laat, Dana Huskens, Yaqiu Sang, Frits R. Rosendaal, Ale Algra, Bob Siegerink, Johan W. M. Heemskerk and Ronald H. W. M. Derksen. Their work appears in journals such as Journal of Thrombosis and Haemostasis, PLoS ONE, Blood, Thrombosis and Haemostasis and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.